Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond K Cross

Showing results (31-40 of 210) with videos related to

Pageof 21
Sort By:
Digestive Diseases and Sciences|June 6, 2018
More Skin in the Game: Screening for Skin Cancer in IBD PatientsSeema A Patil, Raymond K Cross
The American Journal of Gastroenterology|December 30, 2022
Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to StopJordan E Axelrad, Raymond K Cross
Inflammatory Bowel Diseases|September 11, 2019
How Do We Sequence Biologic Therapies in 2019?Lauren A George, Raymond K Cross
Current Gastroenterology Reports|February 2, 2013
Update in the management of extraintestinal manifestations of inflammatory bowel diseaseSeema A Patil, Raymond K Cross
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2013
To yeast or not to yeast: a probiotic questionSandra M Quezada, Raymond K Cross
Expert Review of Gastroenterology & Hepatology|June 22, 2017
Medical versus surgical management of penetrating Crohn's disease: the current situation and future perspectivesSeema A Patil, Raymond K Cross
Inflammatory Bowel Diseases|January 30, 2020
Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease Extends beyond HospitalizationAndrea C Bafford, Raymond K Cross
Gastroenterology Clinics of North America|October 30, 2020
Treatment of Ulcerative Colitis with Steroids (in Whom, How Long, What Dose, What Form)Lauren A George, Raymond K Cross
Expert Review of Gastroenterology & Hepatology|August 7, 2014
What is the need for comparative effectiveness studies in IBD?Mark H Flasar, Raymond K Cross
Expert Review of Gastroenterology & Hepatology|February 5, 2014
Adverse events in IBD: to stop or continue immune suppressant and biologic treatmentLeon P McLean, Raymond K Cross
Pageof 21

Showing results (31-40 of 210) with videos related to

Sort By:
Pageof 21
Digestive Diseases and Sciences|June 6, 2018
More Skin in the Game: Screening for Skin Cancer in IBD PatientsSeema A Patil, Raymond K Cross
The American Journal of Gastroenterology|December 30, 2022
Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to StopJordan E Axelrad, Raymond K Cross
Inflammatory Bowel Diseases|September 11, 2019
How Do We Sequence Biologic Therapies in 2019?Lauren A George, Raymond K Cross
Current Gastroenterology Reports|February 2, 2013
Update in the management of extraintestinal manifestations of inflammatory bowel diseaseSeema A Patil, Raymond K Cross
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2013
To yeast or not to yeast: a probiotic questionSandra M Quezada, Raymond K Cross
Expert Review of Gastroenterology & Hepatology|June 22, 2017
Medical versus surgical management of penetrating Crohn's disease: the current situation and future perspectivesSeema A Patil, Raymond K Cross
Inflammatory Bowel Diseases|January 30, 2020
Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease Extends beyond HospitalizationAndrea C Bafford, Raymond K Cross
Gastroenterology Clinics of North America|October 30, 2020
Treatment of Ulcerative Colitis with Steroids (in Whom, How Long, What Dose, What Form)Lauren A George, Raymond K Cross
Expert Review of Gastroenterology & Hepatology|August 7, 2014
What is the need for comparative effectiveness studies in IBD?Mark H Flasar, Raymond K Cross
Expert Review of Gastroenterology & Hepatology|February 5, 2014
Adverse events in IBD: to stop or continue immune suppressant and biologic treatmentLeon P McLean, Raymond K Cross
Pageof 21